ImmunoPrecise Antibodies
IPA
$1.00
Share price
0.00%
Change (1 day)
-68.25%
Change (1 year)
Categories
Market capitalization of ImmunoPrecise Antibodies (IPA)
Market cap: $26.31 Million
As of June 2024 ImmunoPrecise Antibodies has a market cap of $26.31 Million. This makes ImmunoPrecise Antibodies the world's 8046th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmunoPrecise Antibodies from 2009 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $26.31 M | -41.52% |
| 2023 | $44.99 M | -65.36% |
| 2022 | $0.12 B | 24.75% |
| 2021 | $0.10 B | -58.56% |
| 2020 | $0.25 B | 739.37% |
| 2019 | $29.93 M | -12.68% |
| 2018 | $34.28 M | 55.86% |
| 2017 | $21.99 M | 73.18% |
| 2016 | $12.7 M | 118311.8% |
| 2015 | $0.01 M | -93.81% |
| 2014 | $0.17 M | 250% |
| 2013 | $0.04 M | |
| 2011 | $0.6 M | -75.51% |
| 2010 | $2.47 M | -10.26% |
| 2009 | $2.75 M |
End of Day market cap according to different sources
On Jun 25th, 2024 the market cap of ImmunoPrecise Antibodies was reported to be:
$26.31 Million
$26.31 Million
$26.31 Million
$26.31 Million